Cemiplimab-rwlc for Unresectable Locally Recurrent and/or Metastatic CSCC

Clinical trial NCT04242173 · TERMINATED

Trial details

NCT number: NCT04242173
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Cutaneous Squamous Cell Carcinoma Cutaneous Squamous Cell Carcinoma of the Head and Neck

Start date: 2020-06-25
Primary completion: 2022-05-26
Enrollment: 3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.